Molecular farming for food

Molecular farming for food genetically engineers ordinary food crops to express a single target animal protein directly in the seed or tuber, turning the plant itself into the production bioreactor rather than a fermentation tank or a bioreactor of cultured cells. Moolec Science announced a molecular-farming breakthrough in April 2026, successfully expressing bovine myoglobin — an iron-rich, heme-containing protein — in pea seeds. PoLoPo has filed for USDA approval of its SuperAA platform, which genetically engineers potatoes to produce the egg proteins patatin and ovalbumin. Mozza Foods is targeting a late-2028 launch of soybean-grown casein, pending USDA approval to grow the genetically modified crop and FDA approval to sell the extracted dairy protein — illustrating how the regulatory timeline, not the plant biology, is now the sector’s critical path. Nomad Bioscience already has secured US regulatory approval for one plant-made product, Thaumatin II, a natural super-sweet protein, commercialized through its NAMBAWAN Biotech food-market spin-off.

Key directions of molecular farming for food:

1. Animal-identical protein expression in seed crops (Animal-Identical Protein Expression in Seed Crops): engineering pea, soy or other seed crops to express a specific animal protein (myoglobin, casein) at harvest-ready scale.
2. Tuber-based egg-protein production (Tuber-Based Egg-Protein Production): engineering potatoes to produce named egg proteins (patatin, ovalbumin) as a plant-grown egg-replacement platform.
3. Sweet/functional protein commercialization (Sweet/Functional Protein Commercialization): plant-made specialty proteins (natural sweeteners like thaumatin) reaching market through a dedicated food-market spin-off ahead of the sector’s animal-protein-replacement products.
4. Dual USDA/FDA regulatory gating (Dual USDA/FDA Regulatory Gating): molecular-farming food products need both a GM-crop cultivation approval (USDA) and a food-ingredient sale approval (FDA), a two-step gate distinct from single-agency review in fermentation or cell-culture proteins.

Sectoral value chain#

[target protein selection] ──> [crop genetic engineering] ──> [field/greenhouse cultivation] ──> [protein extraction]
                                                                       │
                                                             (dual USDA/FDA
                                                              regulatory review)
                                                                       │
                                                                       ▼
[food ingredient sale] <─── [purification & formulation] <───────────┘

Value chain levels#

Cross-cutting technologies of the sector:

• Seed/tuber-specific promoter engineering (Seed/Tuber-Specific Promoter Engineering): genetic constructs that direct target-protein expression specifically to the harvestable seed or tuber tissue.
• Heme/iron-protein plant expression (Heme/Iron-Protein Plant Expression): engineering plants to fold and accumulate iron-containing proteins like myoglobin, historically difficult outside animal or microbial hosts.
• Dual-agency regulatory dossier design (Dual-Agency Regulatory Dossier Design): structuring a single molecular-farming product’s evidence package to satisfy both a crop-cultivation regulator and a food-ingredient regulator.

The stack turns crop genetic engineering into a food-protein production system.

1. Seed/tuber-specific expression engineering (Seed/Tuber-Specific Expression Engineering):
   • genetic constructs direct protein accumulation specifically to the harvestable seed or tuber rather than the whole plant.
   • case: PoLoPo’s SuperAA platform expresses named egg proteins specifically in potato tubers.
2. Heme-protein plant folding (Heme-Protein Plant Folding):
   • plants are engineered to correctly fold and accumulate iron-containing heme proteins, a historically difficult target outside animal/microbial hosts.
   • case: Moolec Science’s successful bovine myoglobin expression in pea seeds is described as a molecular-farming breakthrough specifically because of this folding challenge.
3. Dual-agency regulatory dossier structuring (Dual-Agency Regulatory Dossier Structuring):
   • a single product’s evidence package is built to satisfy both a crop-cultivation regulator (USDA) and a food-ingredient regulator (FDA) in sequence.
   • case: Mozza Foods’ soybean-grown casein timeline is explicitly paced by this two-step approval sequence rather than by production scale-up.